Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins

被引:51
作者
BouHamdan, M
Xue, YN
Baudat, Y
Hu, BC
Sire, J
Pomerantz, RJ
Duan, LX [1 ]
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med,Div Infect Dis, Ctr Human Virol,Dorrance H Hamilton Labs, Philadelphia, PA 19107 USA
[2] INSERM, U372, F-13276 Marseille 9, France
关键词
D O I
10.1074/jbc.273.14.8009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Targeting protein or RNA moieties to specific cellular compartments may enhance their desired functions and specificities, Human immunodeficiency virus type I (HIV-1) encodes proteins in addition to Gag, Pol, and Env that are packaged into virus particles, One such retroviral-incorporated protein is Vpr, which is present in all primate lentiviruses, Vpr has been implicated in different roles within the HIV-1 life cycle, In testing a new hypothesis in which viral proteins are utilized as docking sites to incorporate protein moieties into virions, we used the peptide phage display approach to search for Vpr-specific binding peptides, In the present studies, we demonstrate that most of the peptides that bind to Vpr have a common motif, WXXF, More importantly, we demonstrate that the WXXF motif of uracil DNA glycosylase is implicated in the interaction of uracil DNA glycosylase with Vpr intracellularly. Finally, a dimer of the WXXF motif was fused to the chloramphenicol acetyl transferase (CAT) gene, and it was demonstrated that the WXXF dimer-CAT fusion protein construct produces CAT activity within virions in the presence of Vpr as a docking protein, This study provides a novel potential strategy in the targeting of antiviral agents to interfere with HIV-1 replication.
引用
收藏
页码:8009 / 8016
页数:8
相关论文
共 61 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   The human immunodeficiency virus type 1 Vpr transactivator: Cooperation with promoter-bound activator domains and binding to TFIIB [J].
Agostini, I ;
Navarro, JM ;
Rey, F ;
Bouhamdan, M ;
Spire, B ;
Vigne, R ;
Sire, J .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 261 (05) :599-606
[3]   DISTINCT EFFECTS IN PRIMARY MACROPHAGES AND LYMPHOCYTES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACCESSORY GENES VPR, VPU, AND NEF - MUTATIONAL ANALYSIS OF A PRIMARY HIV-1 ISOLATE [J].
BALLIET, JW ;
KOLSON, DL ;
EIGER, G ;
KIM, FM ;
MCGANN, KA ;
SRINIVASAN, A ;
COLLMAN, R .
VIROLOGY, 1994, 200 (02) :623-631
[4]  
BARTEL P, 1993, BIOTECHNIQUES, V14, P920
[5]   Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme [J].
Bouhamdan, M ;
Benichou, S ;
Rey, F ;
Navarro, JM ;
Agostini, I ;
Spire, B ;
Camonis, J ;
Slupphaug, G ;
Vigne, R ;
Benarous, R ;
Sire, J .
JOURNAL OF VIROLOGY, 1996, 70 (02) :697-704
[6]   HUMAN SOS1 - A GUANINE-NUCLEOTIDE EXCHANGE FACTOR FOR RAS THAT BINDS TO GRB2 [J].
CHARDIN, P ;
CAMONIS, JH ;
GALE, NW ;
VANAELST, L ;
SCHLESSINGER, J ;
WIGLER, MH ;
BARSAGI, D .
SCIENCE, 1993, 260 (5112) :1338-1343
[7]  
COHEN EA, 1990, J ACQ IMMUN DEF SYND, V3, P11
[8]   HUMAN-IMMUNODEFICIENCY-VIRUS VPR PRODUCT IS A VIRION-ASSOCIATED REGULATORY PROTEIN [J].
COHEN, EA ;
DEHNI, G ;
SODROSKI, JG ;
HASELTINE, WA .
JOURNAL OF VIROLOGY, 1990, 64 (06) :3097-3099
[9]   VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES [J].
CONNOR, RI ;
CHEN, BK ;
CHOE, S ;
LANDAU, NR .
VIROLOGY, 1995, 206 (02) :935-944
[10]   INFECTION OF HUMAN-CELLS WITH MURINE AMPHOTROPIC REPLICATION-COMPETENT RETROVIRUSES [J].
CORNETTA, K ;
NGUYEN, N ;
MORGAN, RA ;
MUENCHAU, DD ;
HARTLEY, JW ;
BLAESE, RM ;
ANDERSON, WF .
HUMAN GENE THERAPY, 1993, 4 (05) :579-588